Table 3.

Relationship between measures of renal function and cardiovascular risk factors, inflammation, and coronary calcium score in patients with rheumatoid arthritis.

Cystatin CCreatinineMDRD-eGFR
FactorRhop*Adjusted p**Rhop*Adjusted p**Rhop*Adjusted p**
Age0.442< 0.0010.1820.02−0.329< 0.001
Body mass index−0.0960.220.36−0.1340.090.580.1200.120.56
Systolic blood pressure0.1980.010.890.0950.220.30−0.1540.050.32
Diastolic blood pressure0.1160.140.660.1130.150.80−0.0190.810.95
HDL cholesterol−0.1490.060.02−0.0720.360.87−0.0320.680.95
LDL cholesterol−0.0420.590.36−0.1360.080.120.1120.150.20
Homocysteine0.493< 0.001< 0.0010.355< 0.0010.004−0.2380.0020.02
Framingham score0.438< 0.0010.020.0380.630.63−0.2370.0020.57
Disease duration0.1490.060.83−0.0820.290.06−0.0140.860.09
DAS28 Index0.1930.010.006−0.0740.350.400.0140.850.37
ESR0.2560.001< 0.001−0.0210.790.88−0.0350.650.50
CRP0.2000.010.01−0.0850.270.460.0450.570.43
TNF-α0.1980.010.110.0210.790.31−0.0230.770.25
IL-60.1040.190.32−0.0570.470.410.0370.640.41
Coronary calcium score0.323< 0.0010.440.2020.010.47−0.1720.030.78
  • Univariate Spearman correlation coefficient (n = 167).

  • * Spearman’s correlation test.

  • ** Multivariable linear regression was used for adjustment of age, race, and sex; except for coronary calcium score, which used proportional odds logistic regression with additional adjustment for Framingham risk score. MDRD-eGFR: Modified Diet in Renal Disease formula estimated glomerular filtration rate; HDL: high-density lipoprotein; LDL: low-density lipoprotein; DAS28: 28-joint Disease Activity Score; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; TNF-α: tumor necrosis factor-α; IL-6 interleukin 6.